Radcliffe Heart Failure Forum

Bringing medical knowledge, insight and innovation to life for HCPs around the world with a special focus on heart failure.
Radcliffe Cardiology.

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Don’t miss this programme which brings together leading faculty to best inform of the latest clinical evidence and real-world application for optimising treatment strategies in #heartfailure with @ProfMartinCowie

👉🏻 https://t.co/TvQi5unSo1

#cardiotwitter #HFrEF #SGLT2

[Radcliffe Heart Failure Forum @RC_HeartFailure]

🌟 Exciting Collaboration Alert! We're proud to partner with SanMed to enhance cardiovascular education in China. This initiative will bring Radcliffe Group’s expert content to thousands of Chinese HCPs, supporting superior patient outcomes and extending our global impact.

[Radcliffe Heart Failure Forum @RC_HeartFailure]

What does the current literature say about catheter ablation with pulmonary vein isolation (PVI) compared to pharmacological treatment of #atrialfibrillation with #amiodarone?

Faggioni et al. provide an overview 👉 https://t.co/2Y7bsFozIH

#CFRJournal #AFib #AF #HeartFailure

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Could #telemedicine (TM) help improve multidisciplinary integrated care for #heartfailure patients? Here, Silva-Cardoso et al. discuss the evolution of TM in HF and foresee the challenges ahead 👉 https://t.co/ptGchSoBMX @JosepComin

#CFRJournal #DigitalHealth #MedEd #CardioEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Hyperkalaemia poses a major challenge in the management of #heartfailure patients, presenting in 16% to 25% of cases.

Here, Ismail et al. discuss pathophysiology and management of hyperkalaemia in #HF 👉 https://t.co/eq9RHBYYW5 @ShelleyZieroth #CFRJournal #CardioEd #Heart

[Radcliffe Heart Failure Forum @RC_HeartFailure]

As a result of the #COVID19 pandemic, the use of #digitalhealth technologies for #heartfailure management has rapidly increased.

Singhal et al. review how #wearables can support patient care and improve outcomes 👉 https://t.co/GexMEBiwCF #CFRJournal #MedEd #CardioTwitter

[Radcliffe Heart Failure Forum @RC_HeartFailure]

The transition of care for #heartfailure patients has stayed the same for the past 45 years, but new structural interventions are on the rise. Here, Dr Jeffrey Park and @hsuradi review the innovations that are improving survival rates 👉 https://t.co/jxpI55MgEN #CFRJournal #MedEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

When the oxygen intake of #heartfailure patients is impared, intervention is required.

Here, Erik H Van Iterson explains what should be considered when evaluating the aerobic exercise capacity of these patients 👉 https://t.co/G8JrDYIc6U

#CFRJournal #CardioEd #BeatHF #MedEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Inotropic agents have been associated with adverse events, but remain key in the management of acute #heartfailure. This article discusses clinical practice, ongoing research and recommendations for their usage 👉 https://t.co/gZWiZGGQaX @IIKONOMIDIS #CFRJournal #CardioEd #MedEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

“Not ready for prime-time”

In this letter to the editor, the authors argue that while red cell distribution width is a marker of a chronic disease, it is not specific to #heartfailure, and therefore should not be used for diagnosis 👉 https://t.co/TmclGDGR0o

#CFRJournal #MedEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

[CASE STUDY] Diarra et al. describe the case of a 29-year-old patient with Devic’s syndrome who developed severe and fatal enterovirus-related #myocarditis after #rituximab therapy 👉 https://t.co/hWLJLDpIFL @BenjaminLongere @DLaunay @Benej20

#CFRJournal #CardioEd #heartfailure

[Radcliffe Heart Failure Forum @RC_HeartFailure]

CardioMEMS, an implantable pressure monitoring device for the pulmonary artery, may reduce heart failure hospitalisations.

This case study by Rali et al. covers a successful CardioMEMS with GBCA implantation in a woman aged 57 👉 https://t.co/H4jmdBD2sC #CFRJournal @aniket_rali

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Why do women remain underrepresented in the field of cardiology? Here, Ersilia DeFilippis (Columbia University Irving Medical Center, New York) et al. suggest strategies to redress this persistent disparity in HF practice 👉 https://t.co/PWjbvp8uqd #CFRJournal #WomenInCardiology

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Are you aware of the benefits of sacubitril with valsartan as a treatment for chronic #heartfailure with reduced ejection fraction (HFrEF)? Dr Mauro Gori et al. review the available data 👉 https://t.co/aVMXja6bCg @MicheleSenni @JJheart_doc @DrDEliaEmilia

#CFRJournal #CardioEd

[Radcliffe Heart Failure Forum @RC_HeartFailure]

It's Mental Health Awareness Week. Here's a list of helpful articles that discuss the important connection between mental health and cardiac health:

👉 https://t.co/NQtqPB8v6B

👉 https://t.co/MXHzeI2nzc

#mentalhealth #takeabreath

[Radcliffe Heart Failure Forum @RC_HeartFailure]

What’s the link between diabetes medication and heart disease?

Data suggests that some types of diabetes medication can reduce instances of CV disease. Dr Tariq Ahmad et al. explain what you need to know 👉 https://t.co/FCCWXICKcT @yaleHFdoc #ECRJournal

[Radcliffe Heart Failure Forum @RC_HeartFailure]

Unfortunately, due to unforeseen circumstances, we have decided to postpone the webinar: Optimising Treatment in HF on 24 March to a later date.

We’ll be in touch with more information soon.

[Radcliffe Heart Failure Forum @RC_HeartFailure]

@radcliffeCARDIO Don't forget to follow @RC_HeartFailure too!

[Radcliffe Heart Failure Forum @RC_HeartFailure]

@radcliffeCARDIO Don't forget to follow @RC_HeartFailure too!

[Radcliffe Cardiology @radcliffeCARDIO]

Learn about the optimal treatment of HF – practical uses, sequencing of drugs, cases & latest data.

Like 💙 this Tweet to join our private live webinar. Interact with leading heart failure specialists via live Q&A and polls. Earn CME credits. Get reminders and info until May.